May 06, 2015 OTC Disclosure & News Service - SILVER SPRING, Md., May 6, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that the Institute of Virology at the...
Dallas, Texas 04/28/2014 (FINANCIALSTRENDS) – Prana Biotechnology Limited (ADR)(NASDAQ:PRAN) has in the past week announced the results of the top-line results after the company declared its ‘12-month Phase II imaging trails’ as part of its Alzheimer’s disease solution matrix. With several companies vying for top drug or therapy to resolve age-related problems...
Before we get into specifics of GNCM, in an exciting series of events aimed at building shareholder value, Pure Hospitality Solution, Inc. (OTCMKTS:PNOW), the creator of Oveedia and the quickly growing Numismatic Specialty Store, Meso Numismatics, announced that the company will award shareholders with a very generous preferred stock...
Dallas, Texas 04/03/2014 (FINANCIALSTRENDS) – iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) has been on the top for quite a long time now and recently has taken a U-turn and is heading on a downward spiral. This sudden fall was seen after 17th March when the Democrats' who were attending the...
Exelixis, Inc. (NASDAQ:EXEL) has released their financials results for the 4Q2016 and FY2016. The company also provided an update on its corporate objectives and upcoming milestones. For its 4Q2016, EXEL recorded a net income of $35.1 million, as compared to a net loss for 4Q2015. Exelixis was able to...
Geron Corporation (NASDAQ:GERN) is due to hold its annual meeting of shareholders on May 9, 2017, at 4:00 pm, PDT. The company has invited all stockholders to attend the meeting, which would be held at its office location, at 149 Commonwealth Drive, Menlo Park, California. Added to this, shareholders...
Shares of (NASDAQ:) are currently up by more than from the open today and are trading at $. More than shares have exchanged hands compared to an average trading volume of . At the current pps, the market cap stands at $. The stock prices of...
In the last trading session, the stock price of Novavax, Inc. (NASDAQ:NVAX) gained over 14% to close the session at $1.62 on more than normal volume. No specific news accounts for this move. Last month, it commenced a Phase II clinical study evaluating the immunogenicity and safety of its...
Galena Biopharma Inc (NASDAQ:GALE) a biopharmaceutical firm committed to the advancement and commercialization of hematology as well as oncology therapeutics issued the report from a meeting of the DSMB for the two IST combination clinical studies with NeuVax™ plus trastuzumab. The studies are being carried out in breast cancer...
Vancouver, British Columbia, Canada – April 17, 2018 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQB:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary bioinformatics and biosynthesis platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, announced that...